Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy

Seminars in Surgical Oncology

Volumn 20, Issue 1, 2001, Pages 24-32

  Dunst, Juergen ^a   Rödel, Claus ^b   Zietman, Anthony ^c   Schrott, Karl M ^b   Sauer, Rolf ^b   Shipley, William U ^c  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adjuvant; Bladder neoplasms; Chemotherapy; Drug therapy; Radiotherapy; Urologic surgical procedures

Indexed keywords

PLATINUM;

BLADDER CANCER; BLADDER FUNCTION; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CONSERVATIVE TREATMENT; CYSTECTOMY; HUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL RATE; TRANSURETHRAL RESECTION;

HUMANS; MUSCLE NEOPLASMS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0035048564     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/ssu.1013     Document Type: Review

References (55)

1. Invasive transitional cell carcinoma of the bladder: Prognosis and management
2. Radical cystectomy for invasive bladder cancer: Contemporary results and remaining controversies
3. The ileal neobladder: Complications and functional results in 363 patients after 11 years of follow-up
4. The orthotopic Kock ileal neobladder: Functional results, urodynamic features, complications and survival in 166 men
5. How expert physicians would wish to be treated if they had genitourinary cancer
6. Primary radical radiotherapy for T3 transitional cell cancer of the bladder: An analysis of survival and control
7. Organ conservation in bladder cancer
8. Dose fractionation and tumor repopulation in radiotherapy for bladder cancer
9. Blood tests and prognosis in bladder cancer treated by definitive radiotherapy
10. A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer
11. Bladder cancer: Definitive radiation therapy of muscle-invasive bladder cancer
12. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastasis: Long-term results
13. The value of prognostic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate
14. Radical cystectomy for invasive bladder cancer: Contemporary results and remaining controversies
15. Bladder cancer: Superiority of preoperative radiation in cystectomy in clinical stage T3
16. Organ conservation in bladder cancer
17. Treatment of advanced bladder cancer category T2, T3, T4a
18. Invasive bladder cancer: Treatment strategies using transurethral surgery, chemotherapy and radiation therapy with selection for bladder conservation
19. Sequential transurethral surgery, multiple drug chemotherapy and radiation therapy for invasive bladder carcinoma: Initial report
20. Treatment of advanced bladder carcinoma with irradiation and concomitant 5-fluorouracil infusion
21. Combined radiation and cisplatin for locally advanced carcinoma of the urinary bladder
22. Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of RTOG protocol 85-12
23. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study
24. Organ-sparing treatment of advanced bladder cancer: A 10-year experience
25. Neoadjuvant combined modality therapy with possible organ preservation for invasive bladder cancer
26. Bladder preservation by combined modality therapy for invasive bladder cancer
27. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation and chemotherapy: Initial results of Radiation Therapy Oncology Group 89-03
28. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer
29. Invasive bladder cancer: A single-institution experience with bladder sparing approach
30. Bladder cancer: The selection of patients for treatment by full-dose irradiation
31. Primary radical radiotherapy for T3 transitional cell cancer of the bladder: An analysis of survival and local control
32. The results of treatment of cancer of the bladder - A clinical contribution to radiobiology
33. Treatment of T3 bladder cancer: Controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy
34. Irradiation therapy with multiple small fractions per day in urinary bladder cancer
35. Radiotherapy with and without cisplatin in bladder cancer
36. Radiotherapy alone or radiochemotherapy with platinum derivates following transurethral resection of the bladder. Organ preservation and survival after treatment of bladder cancer
37. Combined 5-fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder
38. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation
39. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluoruracil and twice daily irradiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer
40. Concomitant radiochemotherapy with 5-FU and cisplatin for invasive bladder cancer. Acute toxicity and first results
41. Preliminary results of simultaneous radiochemotherapy with paclitaxel for urinary bladder cancer
42. Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: A well-tolerated combination
43. The management of deeply infiltrating (T3) bladder carcinoma: Controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy
44. Salvage cystectomy for bladder carcinoma
45. Bladder cancer: Pattern of recurrence in 142 patients
46. Bladder cancer: Experience with radical and preoperative radiotherapy in 421 patients
47. Recurrence and treatment of urinary bladder cancer after failure in radiotherapy
48. Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy
49. Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma
50. Conservative management of muscle-infiltrating bladder cancer: Prospective experience
51. Radiotherapy for T2 and T3 carcinoma of the bladder: The influence of overall treatment time
52. A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer
53. The management and outcome of bladder carcinoma in Ontario, 1982-1994
54. The current status of bladder preservation in the treatment of muscle invasive bladder cancer